불면증 약물 치료의 최적화 방안

키워드

참고문헌 (51)

1. Qaseem A, "Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians", Annals of Internal Medicine, 165(2), pp.I-26~ (2016), American College of Physicians[DOI]
2. Ong J, "Utilizing cognitive-behavioral therapy for insomnia to facilitate discontinuation of sleep medication in chronic insomnia patients", Sleep Med Res, 3, pp.1~6 (2012)
3. Ohayon MM, "Prevalence of insomnia and associated factors in South Korea", J Psychosom Res, 53, pp.593~600 (2002)
4. 조용원, "Epidemiology of Insomnia in Korean Adults: Prevalence and Associated Factors", Journal of Clinical Neurology, 5(1), pp.20~23 (2009), 대한신경과학회
5. Chung S, "Pattern of hypnotic drug prescription in South Korea: Health Insurance Review and Assessment Service-National Patients Sample", Sleep Med Res, 4, pp.51~55 (2013)
6. Turnheim K, "Drug dosage in the elderly. Is it rational?", Drugs Aging, 13, pp.357~379 (1998)
7. Brodeur MR, "Delirium associated with zolpidem", Ann Pharmacother, 35, pp.1562~1564 (2001)
8. Nzwalo H, "Sleep-related eating disorder secondary to zolpidem", BMJ Case Rep (2013), BMJ[DOI]
9. Zhang B, "Sex differences in insomnia: a meta-analysis", Sleep, 29, pp.85~93 (2006)
10. Stewart R, "Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years", Sleep, 29, pp.1391~1397 (2006)
11. Piccinelli M, "Gender differences in depression. Critical review", Br J Psychiatry, 177, pp.486~492 (2000)
12. Barsky AJ, "Somatic symptom reporting in women and men", J Gen Intern Med, 16, pp.266~275 (2001)
13. Pourshams M, "Zolpidem abuse and dependency in an elderly patient with major depressive disorder: a case report", Daru, 22, pp.54~ (2014)
14. Dorsey CM, "Fluoxetine-induced sleep disturbance in depressed patients", Neuropsychopharmacology, 14, pp.437~442 (1996)
15. Lawrence RW, "Effect of mirtazapine versus fluoxetine on “sleep quality”", J Clin Psychiatry, 65, pp.1149~1150 (2004)
16. I. Stefanidis, "Restless legs syndrome and mortality in hemodialysis patients", Sleep Medicine, 22, pp.103~ (2016), Elsevier BV[DOI]
17. Parker KP, "Hemodialysis disrupts basic sleep reg ulatory mechanisms: building hypotheses", Nurs Res, 49, pp.327~332 (2000)
18. Chen SJ, "The use of benzodiazepine receptor agonists and risk of respiratory failure in patients with chronic obstructive pulmonary disease: a nationwide population-based case-control study", Sleep, 38, pp.1045~1050 (2015)
19. Roth T, "Hypnotic use for insomnia management in chronic obstructive pulmonary disease", Sleep Med, 10, pp.19~25 (2009)
20. Luyster FS, "Comorbid insomnia and obstructive sleep apnea: challenges for clinical practice and research", J Clin Sleep Med, 6, pp.196~204 (2010)
21. Mason M, "Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea", Cochrane Database Syst Rev, (7), pp.CD011090~ (2015)
22. Roberts MB, "Sleep problems are associated with chronic pain over and above mutual associations with depression and catastrophizing", Clin J Pain (2015)
23. Bossini L, "Off-label uses of trazodone: a review", Expert Opin Pharmacother, 13, pp.1707~1717 (2012)
24. Zaal IJ, "Benzodiazepine-associated delirium in critically ill adults", Intensive Care Med, 41, pp.2130~2137 (2015)
25. Grassi L, "Management of delirium in palliative care: a review", Curr Psychiatry Rep, 17, pp.550~ (2015)
26. Soyoung Youn, "Progression of cognitive impairments in idiopathic REM sleep behaviour disorder", Journal of Neurology, Neurosurgery & Psychiatry, 87(8), pp.890~896 (2016), BMJ[DOI]
27. Devnani P, "Management of REM sleep behavior disorder:an evidence based review", Ann Indian Acad Neurol, 18, pp.1~5 (2015)
28. Hardeland R, "Melatonergic drugs in clinical practice", Arzneimittelforschung, 58, pp.1~10 (2008)
29. Shinno H, "Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.522~526 (2010)
30. Hanly P, "Hypnotics should never be used in patients with sleep apnea", J Psychosom Res, 37(Suppl 1), pp.59~65 (1993)
31. Berry RB, "Effect of zolpidem on the effcacy of continuous positive airway pressure as treatment for obstructive sleep apnea", Sleep, 29, pp.1052~1056 (2006)
32. Smales ET, "Trazodone effects on obstructive sleep apnea and non-REM arousal threshold", Ann Am Thorac Soc, 12, pp.758~764 (2015)
33. Sigel E, "The benzodiazepine binding site of GABAA receptors", Trends Pharmacol Sci, 18, pp.425~429 (1997)
34. French DD, "Advances in Patient Safety: From Research to Implementation (Volume 1: Research Findings)" (2005), Agency for Healthcare Research and Quality
35. Hausken AM, "Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors", Eur J Clin Pharmacol, 65, pp.295~301 (2009)
36. Rush CR, "Behavioral pharmacology of zolpidem relative to benzodiazepines:a review", Pharmacol Biochem Behav, 61, pp.253~269 (1998)
37. Zammit G, "Zolpidem extended-release: therapy for sleep induction and sleep maintenance diffculties", Expert Opin Drug Metab Toxicol, 4, pp.325~331 (2008)
38. MacFarlane J, "Hypnotics in insomnia: the experience of zolpidem", Clin Ther, 36, pp.1676~1701 (2014)
39. Altun A, "Melatonin: therapeutic and clinical utilization", Int J Clin Pract, 61, pp.835~845 (2007)
40. Lewy AJ, "Light suppresses melatonin secretion in humans", Science, 210, pp.1267~1269 (1980)
41. Turek FW, "Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists", Sleep Med, 5, pp.523~532 (2004)
42. Krystal AD, "Effcacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia", Sleep, 34, pp.1433~1442 (2011)
43. Mendelson WB, "A review of the evidence for the effcacy and safety of trazodone in insomnia", J Clin Psychiatry, 66, pp.469~476 (2005)
44. Rihmer Z, "Mirtazapine--pharmacologic action and clinical advantages", Neuropsychopharmacol Hung, 11, pp.35~40 (2009)
45. Matreja PS, "Effcacy and safety of add on low-dose mirtazapine in depression", Indian J Pharmacol, 44, pp.173~177 (2012)
46. Minkel J, "Optimizing the pharmacologic treatment of insomnia:current status and future horizons", Sleep Med Clin, 8, pp.333~350 (2013)
47. Chung S, "Sleeping pill administration time and patient subjective satisfaction", J Clin Sleep Med, 12, pp.57~62 (2016)
48. Wade AG, "Effcacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes", Curr Med Res Opin, 23, pp.2597~2605 (2007)
49. Lemoine P, "Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects", J Sleep Res, 16, pp.372~380 (2007)
50. Parrott AC, "The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review", Psychopharmacology (Berl), 71, pp.173~179 (1980)
51. Chung S, "The effectiveness of prolonged-release melatonin in primary insomnia patients with a regular sleep-wake cycle", Sleep Med Res (2016)

관련 논문AI추천